Soraya Mehrabi

Cellular and Molecular Research Center

H指数:16

被引数:1,252

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A meta-analytic approach to identification of clinical biomarkers of hearing loss in cognitive impairment

Neurological Sciences

IF2.4

2026-01-060

PRE

Enhanced spinal cord injury repair by nerve extracellular matrix/carboxymethyl chitosan /oxidized alginate hydrogel containing OE-MSCs

通过含OE-MSCs的神经细胞外基质/羧甲基壳聚糖/氧化海藻酸盐水凝胶增强脊髓损伤修复

Carbohydrate Polymers

IF12.5

2025-11-030

PRE

Biomaterials for CNS disorders: a review of development from traditional methods to AI-assisted optimization

用于中枢神经系统紊乱的生物材料：从传统方法到人工智能辅助优化的开发综述

Journal of Materials Science: Materials in Medicine

IF0

2025-10-140

Nesfatin1 attenuates autism-like behavior via antioxidant, anti-inflammatory activities in a prenatal valproic acid-induced rat model of autism

Nesfatin1通过抗氧化和抗炎活性，在孕前丙戊酸诱导的自闭症大鼠模型中减轻自闭症样行为。

Neuropeptides

IF2.7

2025-09-130

PRE

RETRACTION: The Interplay of Tau Protein and β-Amyloid: While Tauopathy Spreads More Profoundly Than Amyloidopathy, Both Processes Are Almost Equally Pathogenic (Retraction of Vol 41, Pg 1339, 2020)

CELLULAR AND MOLECULAR NEUROBIOLOGY

IF4.8

2024-03-210

Kolaviron neuroprotective effect against okadaic acid-provoked cognitive impairment

HELIYON

IF3.6

2024-02-014

OAAI

Astaxanthin ameliorates spinal cord edema and astrocyte activation via suppression of HMGB1/TLR4/NF-κB signaling pathway in a rat model of spinal cord injury

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2023-05-059

PRE

A photoactive injectable antibacterial hydrogel to support chemo-immunotherapeutic effect of antigenic cell membrane and sorafenib by near-infrared light mediated tumor ablation

MATERIALS TODAY BIO

IF10.2

2023-04-0110

OAAI

Comparison of intranasal and intraperitoneal administration of Eugenia caryophyllata (clove) essential oil on spatial memory, anxiety-like behavior and locomotor activity in a pilocarpine-induced status epilepticus rat model

BMC COMPLEMENTARY MEDICINE AND THERAPIES

IF3.4

2022-08-302

OAAI

Astaxanthin Modulates Autophagy, Apoptosis, and Neuronal Oxidative Stress in a Rat Model of Compression Spinal Cord Injury

虾青素调节大鼠压迫性脊髓损伤模型中的自噬，凋亡和神经元氧化应激

NEUROCHEMICAL RESEARCH

IF3.8

2022-04-189

PRE

Acetyl-L-carnitine confers neuroprotection against lipopolysaccharide (LPS) -induced neuroinflammation by targeting TLR4/NFκB, autophagy, inflammation and oxidative stress (Mar, 10.1007/s11011-021-00715-6, 2021)

METABOLIC BRAIN DISEASE

IF3.5

2021-03-311

Acetyl-L-carnitine confers neuroprotection against lipopolysaccharide (LPS) -induced neuroinflammation by targeting TLR4/NFκB, autophagy, inflammation and oxidative stress

METABOLIC BRAIN DISEASE

IF3.5

2021-03-1229

PREAI

The Roles of Serotonin in Neuropsychiatric Disorders

CELLULAR AND MOLECULAR NEUROBIOLOGY

IF4.8

2021-03-02175

PREAI

Combination Therapy of Killing Diseases by Injectable Hydrogels: From Concept to Medical Applications

ADVANCED HEALTHCARE MATERIALS

IF9.6

2020-12-04127

PREAI

Thermo-responsive chitosan hydrogel for healing of full-thickness wounds infected with XDR bacteria isolated from burn patients: In vitro and in vivo animal model

热响应性壳聚糖水凝胶用于烧伤患者XDR细菌感染的全层伤口的愈合: 体外和体内动物模型

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2020-12-0140

PREAI

RETRACTED: The Interplay of Tau Protein and β-Amyloid: While Tauopathy Spreads More Profoundly Than Amyloidopathy, Both Processes Are Almost Equally Pathogenic (Retracted Article)

CELLULAR AND MOLECULAR NEUROBIOLOGY

IF4.8

2020-07-2215

PREAI

Mesenchymal stem cell mediated effects on microglial phenotype in cuprizone-induced demyelination model

JOURNAL OF CELLULAR BIOCHEMISTRY

IF2.8

2019-04-0834

PREAI

Evaluation of metformin effects in the chronic phase of spontaneous seizures in pilocarpine model of temporal lobe epilepsy

METABOLIC BRAIN DISEASE

IF3.5

2017-10-2746

PREAI

Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial

SCHIZOPHRENIA RESEARCH

IF3.5

2017-06-0122

PREAI

Lack of the effect of bumetanide, a selective NKCC1 inhibitor, in patients with schizophrenia: A double-blind randomized trial

PSYCHIATRY AND CLINICAL NEUROSCIENCES

IF6.2

2016-12-2112

OAAI

Soraya Mehrabi

个人简介

教育背景

工作经历

荣誉奖项

研究方向